ABSOLUTE BIOAVAILABILITY AND DOSE PROPORTIONALITY OF BETAXOLOL IN NORMAL HEALTHY-SUBJECTS

被引：14

作者：

LUDDEN, TM

BOYLE, DA

GIESEKER, D

KENNEDY, GT

CRAWFORD, MH

LUDDEN, LK

CLEMENTI, WA

机构：

[1] UNIV TEXAS,HLTH SCI CTR,DEPT PHARMACOL,SAN ANTONIO,TX 78284

[2] UNIV TEXAS,HLTH SCI CTR,DEPT MED,SAN ANTONIO,TX 78284

[3] LOREX PHARMACEUT,SKOKIE,IL

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1988年 / 77卷 / 09期

关键词：

D O I：

10.1002/jps.2600770913

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：779 / 783

页数：5

共 25 条

[1]

ALPERT MA, 1984, CIRCULATION, V70, P45

[2] OBSERVATIONS ON THE EFFICACY AND PHARMACOKINETICS OF BETAXOLOL (SL 75212), A CARDIOSELECTIVE BETA-ADRENOCEPTOR BLOCKING DRUG [J].

BALNAVE, K ;

NEILL, JD ;

RUSSELL, CJ ;

HARRON, DWG ;

LEAHEY, WJ ;

WILSON, R ;

SHANKS, RG .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 11 (02) :171-180

[3] THE NONMEM SYSTEM [J].

BEAL, S ;

SHEINER, L .

AMERICAN STATISTICIAN, 1980, 34 (02) :118-119

[4] BETAXOLOL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN HYPERTENSION [J].

BERESFORD, R ;

HEEL, RC .

DRUGS, 1986, 31 (01) :6-28

[5]

BERGIS K, 1983, LERS MONOGRAPHIC SER, V1, P51

[6]

BIANCHETTI G, 1980, ARZNEIMITTEL-FORSCH, V30-2, P1912

[7]

BIANCHETTI G, 1979, BRIT J CLIN PHARMACO, V8, pP403

[8] SENSITIVE GAS-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION IN BLOOD AND URINE OF SL-75212 [4-(2-CYCLOPROPYLMETHOXYETHYL)-1-PHENOXY-3-ISOPROPYLAMINOPROPAN-2-OL],A NEW BETA-1 ADRENOCEPTOR BLOCKING-AGENT [J].

BIANCHETTI, G ;

GANANSIA, J ;

MORSELLI, PL .

JOURNAL OF CHROMATOGRAPHY, 1979, 176 (01) :134-139

[9] PHARMACOKINETICS OF BETAXOLOL IN MIDDLE-AGED PATIENTS [J].

BIANCHETTI, G ;

THIERCELIN, JF ;

THENOT, JP .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 31 (02) :231-233

[10]

BIANCHETTI G, 1983, LERS MONOGRAPHIC SER, V1, P51

← 1 2 3 →